![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, June 28, 2018 1:17:11 PM
Celgene Corporation $76.50
Cellectis $28.00
Eureka (private company)
Juno Therapeutics (acquired by Celgenein 03/2018 9 billion)
Kite Pharma (acquired by Gilead for $11.9 billion)
Novartis AG (private company)
Sorrento Therapeutics $7.00
As LA pointed out, IMUN IS IN SOME GOOD COMPANY IN THIS REPORT!
Another thing to keep in mind is the price tag on the Juno and Kite buyouts. This is a good sign for both Cytocom/IMUN, if there are any future offers by the big players to acquire either. Cytocom being the main one, IMO, because of the U.S. patents, trials, research etc.
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM